JF
XFOR icon

Jump Financial’s X4 Pharmaceuticals XFOR Stock Holding History

Jump Financial’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Buy
34,253
+21,936
+178% +$90K ﹤0.01% 1878
2026
Q1 		$50.9K Buy
+12,317
New +$46.1K ﹤0.01% 1788
2024
Q3 		– Sell
-345
Closed -$6.01K – 2178
2024
Q2 		$6.01K Buy
+345
New +$11.3K ﹤0.01% 1737

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jump Financial's XFOR Position: Q2 2026 in Review

Jump Financial increased its X4 Pharmaceuticals (XFOR) stake by 178% in Q2 2026, buying an estimated $90K and bringing the position to 34,253 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

Jump Financial first reported a position in XFOR in Q2 2024 and has held it in 3 quarters since. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Jump Financial held 34,253 shares of X4 Pharmaceuticals worth $160K as of Q2 2026.
  • Jump Financial bought 21,936 X4 Pharmaceuticals shares in Q2 2026, an estimated $90K.
  • X4 Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1878 holding.
  • Jump Financial first reported a position in X4 Pharmaceuticals in Q2 2024 and has held it in 3 quarters since.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.